A 5-decade analysis of 13,715 carcinoid tumors, Cancer, vol.267, issue.4, pp.934-59, 2003. ,
DOI : 10.2214/ajr.163.2.8037065
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors, Endocrinology and Metabolism Clinics of North America, vol.40, issue.1, pp.1-18, 2011. ,
DOI : 10.1016/j.ecl.2010.12.005
Surgical treatment of neuroendocrine metastases, Best Practice & Research Clinical Gastroenterology, vol.19, issue.4, pp.577-83, 2005. ,
DOI : 10.1016/j.bpg.2005.04.003
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours, Endocrine Related Cancer, vol.15, issue.4, pp.1083-97, 2008. ,
DOI : 10.1677/ERC-08-0017
Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France, Neuroendocrinology, vol.89, issue.2, pp.217-239, 2009. ,
DOI : 10.1159/000151562
Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary, Neuroendocrinology, vol.87, issue.1, pp.47-62, 2008. ,
DOI : 10.1159/000111037
One Hundred Years After ???Carcinoid???: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States, Journal of Clinical Oncology, vol.26, issue.18, pp.3063-72, 2008. ,
DOI : 10.1200/JCO.2007.15.4377
Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, and Magnetic Resonance Imaging, Journal of Clinical Oncology, vol.23, issue.1, pp.70-78, 2005. ,
DOI : 10.1200/JCO.2005.01.013
MR Imaging of Hepatic Metastases Caused by Neuroendocrine Tumors: Comparing Four Techniques, American Journal of Roentgenology, vol.180, issue.1, pp.121-129, 2003. ,
DOI : 10.2214/ajr.180.1.1800121
Spectrum of MRI Appearances of Untreated Metastases of the Liver, American Journal of Roentgenology, vol.181, issue.3, pp.809-826, 2003. ,
DOI : 10.2214/ajr.181.3.1810809
Preoperative detection of hepatic metastases: Comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference, European Journal of Radiology, vol.80, issue.2, pp.245-52, 2011. ,
DOI : 10.1016/j.ejrad.2010.06.027
Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI, European Radiology, vol.30, issue.955, pp.1431-1472, 2010. ,
DOI : 10.2214/ajr.181.3.1810809
High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging, Radiology, vol.268, issue.2, pp.390-399, 2013. ,
DOI : 10.1148/radiol.13121628
Hepatic Metastases From Neuroendocrine Tumors With a ???Thin Slice??? Pathological Examination, Annals of Surgery, vol.251, issue.2, pp.307-317, 2010. ,
DOI : 10.1097/SLA.0b013e3181bdf8cf
Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors, European Journal of Radiology, vol.82, issue.10, 2013. ,
DOI : 10.1016/j.ejrad.2013.06.017
Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor: a case report with review of the literature, Diagnostic Pathology, vol.7, issue.18, pp.148-166, 2013. ,
DOI : 10.1186/1746-1596-7-126
Atypical Cystic Carcinoid Tumors of the Liver, Journal of Clinical Gastroenterology, vol.44, issue.10, pp.256-265, 2010. ,
DOI : 10.1097/MCG.0b013e3181da7714
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images., American Journal of Roentgenology, vol.165, issue.6, pp.1407-1420, 1995. ,
DOI : 10.2214/ajr.165.6.7484575
Carcinoid metastases to the liver: role of triple-phase helical CT MRI of carcinoid tumors: spectrum of appearances in the gastrointestinal tract and liver, Radiology. janv J Magn Reson Imaging JMRI. sept, vol.20614, issue.213, pp.143-50261, 1998. ,
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas, Endocrine Related Cancer, vol.18, issue.1, pp.51-60, 2011. ,
DOI : 10.1677/ERC-09-0319
Neuroendocrine tumor liver metastases: use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion, Radiology. avr World J Radiol. 28 nov, vol.2632, issue.111, pp.139-48449, 2010. ,
Metastatic Carcinoid Tumors: A Clinical Review, The Oncologist, vol.10, issue.2, pp.123-154, 2005. ,
DOI : 10.1634/theoncologist.10-2-123
Imaging of Neuroendocrine Tumors, Radiologic Clinics of North America, vol.49, issue.3, pp.529-577, 2011. ,
DOI : 10.1016/j.rcl.2011.02.011
Neuroendocrine tumors of midgut and hindgut origin: Tumor-node-metastasis classification determines clinical outcome, Cancer, vol.14, issue.15, pp.3332-3373, 2011. ,
DOI : 10.1677/ERC-06-0074
Hepatobiliary and Pancreatic: Carcinoid tumor with cystic liver metastases Cystic liver metastases from colorectal cancer, J Gastroenterol Hepatol. 1 mars J Surg Oncol. juin, vol.2574, issue.292, pp.647-647148, 2000. ,
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary Recommendations for management of patients with neuroendocrine liver metastases, Neuroendocrinology. Lancet Oncol. janv, vol.9515, issue.21, pp.157-76, 2012. ,